{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2019:XIQJY6HURUGGM6CODEB6XLIVCF","short_pith_number":"pith:XIQJY6HU","canonical_record":{"source":{"id":"1907.00161","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","cross_cats_sorted":["stat.AP","stat.ME"],"title_canon_sha256":"8a133cb610ea6601627bb165bdcf7bf32bf9988ce783f58b68c72ba5c9f05f49","abstract_canon_sha256":"b2720148eea3a8f670410e3ec5c8add63d46073c3c4bb4cc759ab07c9cb225a9"},"schema_version":"1.0"},"canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","source":{"kind":"arxiv","id":"1907.00161","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1907.00161","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"arxiv_version","alias_value":"1907.00161v1","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1907.00161","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"pith_short_12","alias_value":"XIQJY6HURUGG","created_at":"2026-05-18T12:33:33Z"},{"alias_kind":"pith_short_16","alias_value":"XIQJY6HURUGGM6CO","created_at":"2026-05-18T12:33:33Z"},{"alias_kind":"pith_short_8","alias_value":"XIQJY6HU","created_at":"2026-05-18T12:33:33Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2019:XIQJY6HURUGGM6CODEB6XLIVCF","target":"record","payload":{"canonical_record":{"source":{"id":"1907.00161","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","cross_cats_sorted":["stat.AP","stat.ME"],"title_canon_sha256":"8a133cb610ea6601627bb165bdcf7bf32bf9988ce783f58b68c72ba5c9f05f49","abstract_canon_sha256":"b2720148eea3a8f670410e3ec5c8add63d46073c3c4bb4cc759ab07c9cb225a9"},"schema_version":"1.0"},"canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-17T23:41:57.294986Z","signature_b64":"PPPX6ceg1YcZDGhw08pQqtWgxNWL/uPl47gfpEhzAoZ1KuwNmHEWqGr85VX9H2SZE9St/F05escW1nS8ZjW+AA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","last_reissued_at":"2026-05-17T23:41:57.294420Z","signature_status":"signed_v1","first_computed_at":"2026-05-17T23:41:57.294420Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1907.00161","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:41:57Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"NwbclIEhKSrfmbdiDWKoAcR4D/pPFHZyzDs4GAxqwqVtMdgIsvk1CtHcbUnIMib4Oz3bZ6nW1DEQrPRDcrXWAw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-12T04:21:30.054294Z"},"content_sha256":"3a41fe8b2644f77729b9086faac2f28e0a49ada483d2b382a846ee0ffdcb4b49","schema_version":"1.0","event_id":"sha256:3a41fe8b2644f77729b9086faac2f28e0a49ada483d2b382a846ee0ffdcb4b49"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2019:XIQJY6HURUGGM6CODEB6XLIVCF","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"trialr: Bayesian Clinical Trial Designs in R and Stan","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["stat.AP","stat.ME"],"primary_cat":"stat.CO","authors_text":"Kristian Brock","submitted_at":"2019-06-29T07:33:20Z","abstract_excerpt":"This manuscript introduces an \\proglang{R} package called \\pkg{trialr} that implements a collection of clinical trial methods in \\proglang{Stan} and \\proglang{R}. In this article, we explore three methods in detail. The first is the continual reassessment method for conducting phase I dose-finding trials that seek a maximum tolerable dose. The second is EffTox, a dose-finding design that scrutinises doses by joint efficacy and toxicity outcomes. The third is the augmented binary method for modelling the probability of treatment success in phase II oncology trials with reference to repeated mea"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1907.00161","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:41:57Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"MLieo71Z6a68tIvAqKIoDoaPkScrWryfg9srDaXx9hai91Y2I1Dg2Of8MfEnlAUSMlxGAUUjNOAA0VFTmSqkDw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-12T04:21:30.054674Z"},"content_sha256":"a11855fd8a641b3679dc7ca454ed639ed5844889d7ec4fef27b7e7b1509f221d","schema_version":"1.0","event_id":"sha256:a11855fd8a641b3679dc7ca454ed639ed5844889d7ec4fef27b7e7b1509f221d"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/XIQJY6HURUGGM6CODEB6XLIVCF/bundle.json","state_url":"https://pith.science/pith/XIQJY6HURUGGM6CODEB6XLIVCF/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/XIQJY6HURUGGM6CODEB6XLIVCF/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-12T04:21:30Z","links":{"resolver":"https://pith.science/pith/XIQJY6HURUGGM6CODEB6XLIVCF","bundle":"https://pith.science/pith/XIQJY6HURUGGM6CODEB6XLIVCF/bundle.json","state":"https://pith.science/pith/XIQJY6HURUGGM6CODEB6XLIVCF/state.json","well_known_bundle":"https://pith.science/.well-known/pith/XIQJY6HURUGGM6CODEB6XLIVCF/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2019:XIQJY6HURUGGM6CODEB6XLIVCF","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"b2720148eea3a8f670410e3ec5c8add63d46073c3c4bb4cc759ab07c9cb225a9","cross_cats_sorted":["stat.AP","stat.ME"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","title_canon_sha256":"8a133cb610ea6601627bb165bdcf7bf32bf9988ce783f58b68c72ba5c9f05f49"},"schema_version":"1.0","source":{"id":"1907.00161","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1907.00161","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"arxiv_version","alias_value":"1907.00161v1","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1907.00161","created_at":"2026-05-17T23:41:57Z"},{"alias_kind":"pith_short_12","alias_value":"XIQJY6HURUGG","created_at":"2026-05-18T12:33:33Z"},{"alias_kind":"pith_short_16","alias_value":"XIQJY6HURUGGM6CO","created_at":"2026-05-18T12:33:33Z"},{"alias_kind":"pith_short_8","alias_value":"XIQJY6HU","created_at":"2026-05-18T12:33:33Z"}],"graph_snapshots":[{"event_id":"sha256:a11855fd8a641b3679dc7ca454ed639ed5844889d7ec4fef27b7e7b1509f221d","target":"graph","created_at":"2026-05-17T23:41:57Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"This manuscript introduces an \\proglang{R} package called \\pkg{trialr} that implements a collection of clinical trial methods in \\proglang{Stan} and \\proglang{R}. In this article, we explore three methods in detail. The first is the continual reassessment method for conducting phase I dose-finding trials that seek a maximum tolerable dose. The second is EffTox, a dose-finding design that scrutinises doses by joint efficacy and toxicity outcomes. The third is the augmented binary method for modelling the probability of treatment success in phase II oncology trials with reference to repeated mea","authors_text":"Kristian Brock","cross_cats":["stat.AP","stat.ME"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","title":"trialr: Bayesian Clinical Trial Designs in R and Stan"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1907.00161","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:3a41fe8b2644f77729b9086faac2f28e0a49ada483d2b382a846ee0ffdcb4b49","target":"record","created_at":"2026-05-17T23:41:57Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"b2720148eea3a8f670410e3ec5c8add63d46073c3c4bb4cc759ab07c9cb225a9","cross_cats_sorted":["stat.AP","stat.ME"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.CO","submitted_at":"2019-06-29T07:33:20Z","title_canon_sha256":"8a133cb610ea6601627bb165bdcf7bf32bf9988ce783f58b68c72ba5c9f05f49"},"schema_version":"1.0","source":{"id":"1907.00161","kind":"arxiv","version":1}},"canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"ba209c78f48d0c66784e1903ebad151165f314b6b40f983ef0f6b3da4920e779","first_computed_at":"2026-05-17T23:41:57.294420Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:41:57.294420Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"PPPX6ceg1YcZDGhw08pQqtWgxNWL/uPl47gfpEhzAoZ1KuwNmHEWqGr85VX9H2SZE9St/F05escW1nS8ZjW+AA==","signature_status":"signed_v1","signed_at":"2026-05-17T23:41:57.294986Z","signed_message":"canonical_sha256_bytes"},"source_id":"1907.00161","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:3a41fe8b2644f77729b9086faac2f28e0a49ada483d2b382a846ee0ffdcb4b49","sha256:a11855fd8a641b3679dc7ca454ed639ed5844889d7ec4fef27b7e7b1509f221d"],"state_sha256":"9380dda0bbdf93c10b007681d723f0ca3f9885c1a7f5f96c079e52784fb7028b"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"0+2wKJCoSkhQ6QLTLASLcayDJna04yZl2vk/0XFO/fFKFk6haxdheybGQ6N92dlM+/ji1sFHLsz/fnLbaL7RAw==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-12T04:21:30.056732Z","bundle_sha256":"8855fc04bbb3cec754bd34317985ceb7db5b86254e48d2bcda1180d2e2d6b06b"}}